Transamerica Financial Advisors’s Bio-Techne TECH Stock Holding History

Transamerica Financial Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.6K	Buy	51 +41	+410%	+$2.21K	﹤0.01%	1198
2026 Q1	$522	Sell	10 -1	-9%	-$60	﹤0.01%	1474
2025 Q4	$647	Sell	11 -2	-15%	-$122	﹤0.01%	1316
2025 Q3	$723	Buy	+13	New	+$696	﹤0.01%	1228
2019 Q3	–	Sell	-8	Closed	-$1K	–	474
2019 Q2	$1K	Buy	+8	New	+$403	﹤0.01%	525
2019 Q1	–	Sell	-9,200	Closed	-$333K	–	414
2018 Q4	$333K	Buy	9,200 +1,080	+13%	+$45.1K	0.09%	131
2018 Q3	$415K	Sell	8,120 -68	-0.8%	-$3.01K	0.09%	137
2018 Q2	$303K	Buy	+8,188	New	+$313K	0.07%	156

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Transamerica Financial Advisors's TECH Position: Q2 2026 in Review

Transamerica Financial Advisors increased its Bio-Techne (TECH) stake by 410% in Q2 2026, buying an estimated $2.21K and bringing the position to 51 shares worth $3.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1198.

Transamerica Financial Advisors first reported a position in TECH in Q2 2018 and has held it in 8 quarters since. The position peaked at $415K in Q3 2018. 597 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Transamerica Financial Advisors held 51 shares of Bio-Techne worth $3.6K as of Q2 2026.
Transamerica Financial Advisors bought 41 Bio-Techne shares in Q2 2026, an estimated $2.21K.
Bio-Techne made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #1198 holding.
Transamerica Financial Advisors first reported a position in Bio-Techne in Q2 2018 and has held it in 8 quarters since.
Transamerica Financial Advisors's Bio-Techne position peaked at $415K in Q3 2018.
597 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.